2 results
Approved WMOPending
To assess accuracy and reliability of new-to-market CGM systems in patients with type 1 diabetes.
Approved WMOPending
To assess the feasibility of a larger study comparing HFNO with NIV as first line treatment in hypercapnic, acidotic AECOPD.